3.103
price down icon11.85%   -0.417
 
loading

Abvc Biopharma Inc Borsa (ABVC) Ultime notizie

pulisher
09:39 AM

Is ABVC BioPharma Inc. stock a growth or value playAlpha Stock Ideas - Newser

09:39 AM
pulisher
08:43 AM

Is ABVC BioPharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com

08:43 AM
pulisher
01:13 AM

ABVC BioPharma Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com

01:13 AM
pulisher
Jul 20, 2025

What drives ABVC BioPharma Inc. stock priceAccelerated wealth expansion - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about ABVC BioPharma Inc. stockFree Consultation - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 18, 2025

What makes ABVC BioPharma Inc. stock attractive to long term investorsValue Pick Scanner - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program - Yahoo Finance

Jul 18, 2025
pulisher
Jul 15, 2025

What makes ABVC BioPharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ABVC BioPharma Inc. stock attracts strong analyst attentionDaily Gain Forecast - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ABVC BioPharma Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

ABVC BioPharma Soars 16%—Is This the Breakout Biotech Investors Have Been Waiting For? - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships - Yahoo Finance

Jul 10, 2025
pulisher
Jun 26, 2025

ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology - StreetInsider

Jun 26, 2025
pulisher
Jun 24, 2025

ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment - Yahoo Finance

Jun 24, 2025
pulisher
Jun 07, 2025

ABVC BioPharma's Affiliate OncoX Acquires Lycopenoid Platform to Strengthen Oncology Portfolio - citybuzz -

Jun 07, 2025
pulisher
Jun 06, 2025

ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million - The Globe and Mail

Jun 06, 2025
pulisher
Jun 04, 2025

ABVC BioPharma Shareholders Approve Key Proposals - TipRanks

Jun 04, 2025
pulisher
Jun 03, 2025

ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value - Yahoo Finance

Jun 03, 2025
pulisher
Jun 01, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Up 40.0% in May - Defense World

Jun 01, 2025
pulisher
May 26, 2025

3 Top Growth Stocks to Buy in the Second Half of 2025 - The Globe and Mail

May 26, 2025
pulisher
May 22, 2025

ABVC BioPharma Files $100 Million Mixed Shelf - marketscreener.com

May 22, 2025
pulisher
May 14, 2025

ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance - Yahoo Finance

May 14, 2025
pulisher
May 09, 2025

ABVC BioPharma Secures Japanese Patent for Botanical Depression Treatment - citybuzz -

May 09, 2025
pulisher
May 09, 2025

ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504 - Yahoo Finance

May 09, 2025
pulisher
May 01, 2025

ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan - Yahoo Finance

May 01, 2025
pulisher
Apr 30, 2025

ABVC BIOPHARMA, INC. SEC 10-Q Report - TradingView

Apr 30, 2025
pulisher
Apr 26, 2025

ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

Apr 26, 2025
pulisher
Apr 16, 2025

UPDATE: ABVC BioPharma Announces 2024 Financial Results - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

ABVC BioPharma Reports Strong Financial Growth - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

ABVC BioPharma Announces 2024 Financial Results - Yahoo Finance

Apr 15, 2025
$21.82
price up icon 0.67%
$35.83
price up icon 0.55%
$103.39
price up icon 0.67%
$26.32
price up icon 0.15%
$109.96
price up icon 0.27%
biotechnology ONC
$294.68
price up icon 0.93%
Capitalizzazione:     |  Volume (24 ore):